EFTA Document EFTA01485227
J.P.Morgan JEFFREY EPSTEIN ACCT. For the Period 2/1/09 to 2128/09 Cash & Short Term Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation Cash 56.55446 56.59480 30.34 100% Market Value/Cost Current Period Value Market Value Tax Cost Estimated Annual Income Accrued Interest Yield 56584.80 58.584.80 384.21 25.93 0.68% Page 4 of 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00006500 SDN
Summary
J.P.Morgan JEFFREY EPSTEIN ACCT. For the Period 2/1/09 to 2128/09 Cash & Short Term Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation Cash 56.55446 56.59480 30.34 100% Market Value/Cost Current Period Value Market Value Tax Cost Estimated Annual Income Accrued Interest Yield 56584.80 58.584.80 384.21 25.93 0.68% Page 4 of 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00006500 SDN
Ask AI About This Document
Extracted Text (OCR)
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
56.55446
56.59480Related Documents (6)
EFTA01682184
EFTA01370863
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
EFTA00014087
EFTA02367961
EFTA01977826
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.